Heparin Pharmacokinetics and Pharmacodynamics
- 1 May 1992
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 22 (5), 359-374
- https://doi.org/10.2165/00003088-199222050-00003
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mgThe Journal of Clinical Pharmacology, 1988
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986
- Pharmacokinetics of Intravenously and Subcutaneously Administered Fragmin in Healthy VolunteersPathophysiology of Haemostasis and Thrombosis, 1986
- Pharmacokinetic Studies of Standard Heparin and Low Molecular Weight Heparin in Patients with Chronic Renal FailurePathophysiology of Haemostasis and Thrombosis, 1986
- Increased Anti-Xa Bioavailability for a Low Molecular Weight Heparin (PK 10169) Compared with Unfractionated HeparinSeminars in Thrombosis and Hemostasis, 1985
- Kinetics of technetium-labeled heparin in thromboembolism: Preliminary reportInternational Journal of Nuclear Medicine and Biology, 1979
- Heparin therapy: A randomized prospective studyAmerican Heart Journal, 1979
- Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombinFEBS Letters, 1976
- Heparin kinetics in venous thrombosis and pulmonary embolism.Circulation, 1976
- The separation of active and inactive forms of heparinBiochemical and Biophysical Research Communications, 1976